MT-RNR1 POCT

The user will receive a survey report containing device specific performance data, benchmarked against the cohort of participating users. Additionally a annual report summarising the years data will also be provided.

Point-of-Care testing for the MT-RNR1 m.1555A>G variant. Users will receive three EQA samples every two months (18 samples per year), allowing them to verify the ongoing accuracy of MT-RNR1 testing on their POCT devices, to ensure patients receive the most reliable diagnoses possible.  Users are required to report MT-RNR1 m.1555A>G detection status, with additional patient identifiers. Additional samples are available to purchase for device verification. You can purchase a verification package of materials from our website by navigating to the ‘EQA Scheme catalogue’ section, selecting Point of Care Testing.

No restrictions on number of participants. Open to laboratories from ALL countries (note: some restrictions may apply due to sanctions, delivery network exceptions, restrictions on importation etc).